Executive Summary
This $14.9B batch of 10 contract option exercises signals strong U.S. government commitment to long-term programs, led by a massive $10.6B DOE Hanford tank farm management extension (71% of total) underscoring stable revenue for environmental remediation firms. Additional $2.5B+ across DHS Coast Guard shipbuilding/construction and HHS health R&D/NIH contracts highlight multi-year visibility through 2026-2029, with unexercised options offering ~$1.5B+ upside. All bullish signals point to revenue tailwinds for parents like Jacobs, Leidos (x2), Booz Allen, CACI, and Cerus amid low current outlays signaling early-stage funding ramps.
Tracking the trend? Catch up on the prior Contract Option Exercises digest from February 21, 2026.
Investment Signals(4)
- DOE Environmental Remediation Lock-In(HIGH)▲
$11.6B combined obligations (78% of total) for Hanford and West Valley projects provide 1-2 year revenue certainty through 2025-2026 for Jacobs/Amentum.
- Coast Guard Fleet Modernization Momentum(HIGH)▲
$1.5B+ in shipbuilding and base rebuilds to 2026-2027 bolsters Eastern Shipbuilding and AECOM JV with $311M options upside.
- HHS/NIH R&D Revenue Streams(HIGH)▲
$1.4B across eligibility support, pathogen tech, and biomed R&D extends Leidos/Serco/Cerus visibility to 2026-2028 with $59M+ remaining outlays.
- GSA IT/Engineering Services Expansion(MEDIUM)▲
$445M obligations (options to $921M) for Leidos/Booz Allen/CACI through 2026-2029 in contact centers and technical support.
Risk Flags(3)
- Competitive[HIGH RISK]▼
Hanford $10.6B contract ends 2025-02-23, risking recompetition for 30%+ of Amentum/Jacobs DOE revenue.
- Execution[MEDIUM RISK]▼
Low outlays vs obligations (e.g., $448k/$1.4B Eastern; $0/$118M CACI) across 70% of contracts signal potential delays in 13-year spans.
- Execution[MEDIUM RISK]▼
Fixed-price structures in 40% of contracts (e.g., Serco $1B, Leidos $136M) expose to cost overruns; subawards average 30% of value create dependencies.
Opportunities(3)
- ◆
$1.5B+ unexercised options (e.g., $287M CACI, $311M Eastern, $143M Booz Allen) across 80% of contracts.
- ◆
Follow-on potential post-2025 ends in DOE/HHS (Hanford, CMS) given ongoing remediation/R&D mandates.
- ◆
Small/disadvantaged status unlocks BARDA pipeline for Cerus; Coast Guard Phase 2 implies Phase 3.
Sector Themes(3)
- ◆
71% of value in cost-plus Hanford/West Valley extensions to 2025-2026 reflects entrenched spending on nuclear legacy sites.
- ◆
10% of total in OPC ships and PR base rebuilds to 2027 signals fleet recapitalization.
- ◆
10%+ in BARDA/NIH through 2028 prioritizes pathogen/biomed tech amid preparedness focus.
Watch List(3)
- 👁
{"entity"=>"Jacobs Engineering (Hanford/West Valley)", "reason"=>"Controls $11.6B (78% total value) nearing 2025-2026 cliffs.", "trigger"=>"Recompetition RFP or extension award"}
- 👁
{"entity"=>"Leidos Holdings (HHS/GSA)", "reason"=>"$300M dual contracts to 2026-2028 with $36M options.", "trigger"=>"Outlay ramp >20% QoQ or option pulls"}
- 👁
{"entity"=>"CACI International", "reason"=>"$414M option ceiling vs $128M obligated; newest award (2024).", "trigger"=>"Initial outlays or 2029 extension"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 10 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC